UniProt ID | DAAM2_HUMAN | |
---|---|---|
UniProt AC | Q86T65 | |
Protein Name | Disheveled-associated activator of morphogenesis 2 | |
Gene Name | DAAM2 {ECO:0000312|HGNC:HGNC:18143} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1068 | |
Subcellular Localization | ||
Protein Description | Key regulator of the Wnt signaling pathway, which is required for various processes during development, such as dorsal patterning, determination of left/right symmetry or myelination in the central nervous system. Acts downstream of Wnt ligands and upstream of beta-catenin (CTNNB1). Required for canonical Wnt signaling pathway during patterning in the dorsal spinal cord by promoting the aggregation of Disheveled (Dvl) complexes, thereby clustering and formation of Wnt receptor signalosomes and potentiating Wnt activity. During dorsal patterning of the spinal cord, inhibits oligodendrocytes differentiation via interaction with PIP5K1A. Also regulates non-canonical Wnt signaling pathway. Acts downstream of PITX2 in the developing gut and is required for left/right asymmetry within dorsal mesentery: affects mesenchymal condensation by lengthening cadherin-based junctions through WNT5A and non-canonical Wnt signaling, inducing polarized condensation in the left dorsal mesentery necessary to initiate gut rotation. Together with DAAM1, required for myocardial maturation and sarcomere assembly.. | |
Protein Sequence | MAPRKRSHHGLGFLCCFGGSDIPEINLRDNHPLQFMEFSSPIPNAEELNIRFAELVDELDLTDKNREAMFALPPEKKWQIYCSKKKEQEDPNKLATSWPDYYIDRINSMAAMQSLYAFDEEETEMRNQVVEDLKTALRTQPMRFVTRFIELEGLTCLLNFLRSMDHATCESRIHTSLIGCIKALMNNSQGRAHVLAQPEAISTIAQSLRTENSKTKVAVLEILGAVCLVPGGHKKVLQAMLHYQVYAAERTRFQTLLNELDRSLGRYRDEVNLKTAIMSFINAVLNAGAGEDNLEFRLHLRYEFLMLGIQPVIDKLRQHENAILDKHLDFFEMVRNEDDLELARRFDMVHIDTKSASQMFELIHKKLKYTEAYPCLLSVLHHCLQMPYKRNGGYFQQWQLLDRILQQIVLQDERGVDPDLAPLENFNVKNIVNMLINENEVKQWRDQAEKFRKEHMELVSRLERKERECETKTLEKEEMMRTLNKMKDKLARESQELRQARGQVAELVAQLSELSTGPVSSPPPPGGPLTLSSSMTTNDLPPPPPPLPFACCPPPPPPPLPPGGPPTPPGAPPCLGMGLPLPQDPYPSSDVPLRKKRVPQPSHPLKSFNWVKLNEERVPGTVWNEIDDMQVFRILDLEDFEKMFSAYQRHQKELGSTEDIYLASRKVKELSVIDGRRAQNCIILLSKLKLSNEEIRQAILKMDEQEDLAKDMLEQLLKFIPEKSDIDLLEEHKHEIERMARADRFLYEMSRIDHYQQRLQALFFKKKFQERLAEAKPKVEAILLASRELVRSKRLRQMLEVILAIGNFMNKGQRGGAYGFRVASLNKIADTKSSIDRNISLLHYLIMILEKHFPDILNMPSELQHLPEAAKVNLAELEKEVGNLRRGLRAVEVELEYQRRQVREPSDKFVPVMSDFITVSSFSFSELEDQLNEARDKFAKALMHFGEHDSKMQPDEFFGIFDTFLQAFSEARQDLEAMRRRKEEEERRARMEAMLKEQRERERWQRQRKVLAAGSSLEEGGEFDDLVSALRSGEVFDKDLCKLKRSRKRSGSQALEVTRERAINRLNY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
182 | Acetylation | TSLIGCIKALMNNSQ HHHHHHHHHHHCCCC | 39.27 | 20167786 | |
355 | Phosphorylation | MVHIDTKSASQMFEL EEEECCCCHHHHHHH | 34.93 | - | |
482 | Phosphorylation | EKEEMMRTLNKMKDK HHHHHHHHHHHHHHH | 19.45 | 28152594 | |
487 | Acetylation | MRTLNKMKDKLARES HHHHHHHHHHHHHHH | 54.01 | 7429263 | |
512 | Phosphorylation | AELVAQLSELSTGPV HHHHHHHHHHCCCCC | 25.14 | 20071362 | |
589 | Phosphorylation | PQDPYPSSDVPLRKK CCCCCCCCCCCCCCC | 37.82 | 20071362 | |
656 | Phosphorylation | RHQKELGSTEDIYLA HHHHHHCCHHHHHHH | 41.05 | 30266825 | |
657 | Phosphorylation | HQKELGSTEDIYLAS HHHHHCCHHHHHHHH | 35.56 | 30266825 | |
661 | Phosphorylation | LGSTEDIYLASRKVK HCCHHHHHHHHHCCE | 14.45 | 24702127 | |
664 | Phosphorylation | TEDIYLASRKVKELS HHHHHHHHHCCEEEE | 30.00 | 24702127 | |
671 | Phosphorylation | SRKVKELSVIDGRRA HHCCEEEECCCCCHH | 20.37 | 23403867 | |
747 | Phosphorylation | ARADRFLYEMSRIDH HHHHHHHHHHHHHHH | 13.58 | 22817900 | |
765 | Acetylation | RLQALFFKKKFQERL HHHHHHHHHHHHHHH | 47.95 | 19819117 | |
766 | Acetylation | LQALFFKKKFQERLA HHHHHHHHHHHHHHH | 54.38 | 19819125 | |
844 | Phosphorylation | RNISLLHYLIMILEK HHHHHHHHHHHHHHH | 9.63 | 22817900 | |
1015 | Phosphorylation | RKVLAAGSSLEEGGE HHHHHCCCCCCCCCC | 27.33 | 29691806 | |
1016 | Phosphorylation | KVLAAGSSLEEGGEF HHHHCCCCCCCCCCH | 38.59 | 26657352 | |
1050 | Phosphorylation | LKRSRKRSGSQALEV HHHHHCCCCCCHHHH | 45.92 | 26657352 | |
1052 | Phosphorylation | RSRKRSGSQALEVTR HHHCCCCCCHHHHHH | 17.33 | 26657352 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DAAM2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DAAM2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DAAM2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
K1C40_HUMAN | KRT40 | physical | 25416956 | |
RBY1F_HUMAN | RBMY1F | physical | 25416956 | |
KR107_HUMAN | KRTAP10-7 | physical | 25416956 | |
KR101_HUMAN | KRTAP10-1 | physical | 25416956 | |
KR108_HUMAN | KRTAP10-8 | physical | 25416956 | |
KR103_HUMAN | KRTAP10-3 | physical | 25416956 | |
SG2A1_HUMAN | SCGB2A1 | physical | 28514442 | |
AVR2A_HUMAN | ACVR2A | physical | 28514442 | |
CD320_HUMAN | CD320 | physical | 28514442 | |
PRAME_HUMAN | PRAME | physical | 28514442 | |
LGR4_HUMAN | LGR4 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...